Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from the leading medical centers in the United States and Europe critically review the latest scientific advances in our understanding of the molecular genetics and biology of CLL and apply them to its best management. Their comprehensive reviews of the clinical aspects of CLL focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogeneic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several promising new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed.
Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care.
Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care.